Numerous immunotherapies have been utilized in the treatment of various cancer types, however, the effectiveness and response rates among patients are limited [1, 2]. Cancer cells have been found to ...
Management of Diffuse Large B-Cell Lymphoma: Are We Getting Smarter? In the article that accompanies this editorial, Chung et al 16 describe a functional assay, Low-pass Genomic Instability ...
This study demonstrates that NGS-MSI is noninferior to IHC-MMR and can identify MSI-H tumors that IHC-MMR is unable to detect and conversely IHC-MMR can identify MMRd tumors that NGS-MSI misses. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results